Regeneron Pharmaceuticals, Inc.
IT ˙ ETLX ˙ US75886F1075
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT
SecurityIT:4REGN / Regeneron Pharmaceuticals, Inc.
InstitutionGlobal Retirement Partners, LLC
Latest Disclosed Ownership1,499 shares
Latest Disclosed Value $ 1,156,829
Global Retirement Partners, LLC reports 132.76% increase in ownership of 4REGN / Regeneron Pharmaceuticals, Inc.

On February 6, 2026 - Global Retirement Partners, LLC filed a 13F-HR form disclosing ownership of 1,499 shares of Regeneron Pharmaceuticals, Inc. (IT:4REGN) valued at $1,156,829 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 21, 2025 disclosing 644 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of 132.76% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-06 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,499 855 132.76 1,157 219.34 0.0205
2025-10-21 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 644 54 9.15 362 17.15 0.0081
2025-08-12 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 590 106 21.90 310 -10.17 0.0077
2025-01-31 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 484 -147 -23.30 345 -48.11 0.0099
2024-10-16 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 631 193 44.06 663 44.13 0.0200
2024-07-23 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 438 65 17.43 460 28.13 0.0144
2024-04-23 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 373 91 32.27 359 35.98 0.0134
2024-01-18 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 282 33 13.25 264 30.69 0.0111
2023-10-13 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 249 100 67.11 203 88.79 0.0102
2023-07-20 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 149 -2 -1.32 107 -11.57 0.0052
2023-05-08 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 151 18 13.53 121 27.37 0.0064
2023-02-13 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 133 -25 -15.82 96 -19.49 0.0066
2022-11-03 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 158 5 3.27 118 31.11 0.0089
2022-07-15 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 153 -12 -7.27 90 -20.35 0.0072
2022-07-14 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 165 165 113 0.0089
2022-01-21 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -265 -100.00 0 -100.00
2021-10-22 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 265 -38 -12.54 160 -5.33 0.0158
2021-07-15 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 303 -1 -0.33 169 17.36 0.0173
2021-04-14 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 304 -28 -8.43 144 -10.00 0.0169
2021-01-13 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 332 34 11.41 160 -4.19 0.0200
2020-10-09 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 298 -4 -1.32 167 -11.17 0.0244
2020-07-13 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 302 -7 -2.27 188 24.50 0.0300
2020-04-28 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 309 7 2.32 151 33.63 0.0286
2020-01-23 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 302 0 0.00 113 34.52 0.0173
2019-11-19 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 302 0 0.00 84 -11.58 0.0138
2019-11-19 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 302 -15 -4.73 95 -26.92 0.0182
2019-05-07 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 317 60 23.35 130 35.42 0.0314
2019-02-22 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 257 64 33.16 96 23.08 0.0245
2018-10-17 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 193 41 26.97 78 50.00 0.0176
2018-08-13 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 152 19 14.29 52 13.04 0.0131
2018-08-10 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 133 79 146.30 46 130.00 0.0127
2018-08-13 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 54 3 5.88 20 -13.04 0.0055
2018-08-10 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 51 -1 -1.92 23 -11.54 0.0095
2018-08-10 2017-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 52 -2 -3.70 26 23.81 0.0122
2018-08-10 2017-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 54 15 38.46 21 50.00 0.0117
2018-08-10 2016-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 39 39 14 0.0094
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.